Company: CXAI
Filing Date: 2025-08-11
Form Type: S-3
Source: 0001829126-25-006018
Chunk: 55

Company: CXApp Inc.
Filing Date: 2025-08-11
Form: S-3
Chunk 55
---
2025, and after deducting
commissions and estimated offering expenses of approximately $106,000 payable by us, our pro forma as adjusted net tangible book value
as of March 31, 2025 would have been approximately $2.9 million, or $0.09 per share. This represents an immediate increase in pro
forma as adjusted net tangible book value of approximately $0.29 per share to existing stockholders and results in immediate dilution
in net tangible book value to investors purchasing our securities in this offering. The following table illustrates this calculation on
a per share basis:

| Assumed public offering price per share for this offering                                                          
 Historical net tangible book value per share as of March 31, 2025                                                  |     |   | (0.40 | ) |     |   | 0.9263 |   |
|:-------------------------------------------------------------------------------------------------------------------|:----|:--|------:|:--|:----|:--|-------:|:--|
| Pro forma increase per share attributable to the pro forma adjustments                                             |     | $ |  0.20 |   |     |   |        |   |
| Pro forma net tangible book value per share after the pro forma adjustments                                        |     |   |       |   |     | $ |  (0.20 | ) |
| Increase in pro forma as adjusted net tangible book value per share after this offering                            |     | $ |  0.29 |   |     |   |        |   |
| Pro forma as adjusted net tangible book value per share as of March 31, 2025, after giving effect to this offering |     |   |       |   |     | $ |   0.09 |   |
| Dilution per share to new investors                                                                                |     |   |       |   |     | $ | 0.8373 |   |

The foregoing table does not take into account dilution to new investors that could occur upon the exercise of outstanding options and warrants having a per share exercise price less than the assumed public offering price in this offering or shares of common stock issued after March 31, 2025.

The foregoing table is based on 19,805,784 shares of our common stock outstanding as of March 31, 2025, and, excludes, as of that date, the following:

| ● | 1,799,550 shares of common stock issuable upon the exercise of outstanding stock options under the Company